Literature DB >> 23979833

In vivo molecular imaging of apoptosis and necrosis in atherosclerotic plaques using microSPECT-CT and microPET-CT imaging.

M De Saint-Hubert1, M Bauwens, N Deckers, M Drummen, K Douma, P Granton, G Hendrikx, D Kusters, J Bucerius, C P M Reutelingsperger, F M Mottaghy.   

Abstract

PURPOSE: The purpose of this paper is to study molecular imaging of apoptosis and necrosis, two key players in atherosclerosis instability, using a multimodal imaging approach combining single photon emission computed tomography (SPECT), positron emission tomography (PET), and computed tomography (CT). PROCEDURES: Collar-induced carotid atherosclerosis ApoE knockout mice were imaged with (99m)Tc-AnxAF568 SPECT-CT to study apoptosis and sequentially with PET-CT following (124)I-Hypericin ((124)I-Hyp) injection to visualize necrosis.
RESULTS: SPECT depicted increased (99m)Tc-AnxAF568 uptake in both atherosclerotic carotid arteries, whereas our data suggest that this uptake is not merely apoptosis related. Although PET of (124)I-Hyp was hampered by the slow blood clearance in atherosclerotic mice, (124)I-Hyp was able to target necrosis in the atherosclerotic plaque.
CONCLUSION: Both (99m)Tc-AnxAF568 and (124)I-Hyp uptake are increased in atherosclerotic carotid vasculature compared to control arteries. While apoptosis imaging remains challenging, necrosis imaging can be feasible after improving the biodistribution characteristics of the probe.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23979833     DOI: 10.1007/s11307-013-0677-0

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  32 in total

1.  Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis.

Authors:  Bas L J H Kietselaer; Chris P M Reutelingsperger; Guido A K Heidendal; Mat J A P Daemen; Werner H Mess; Leonard Hofstra; Jagat Narula
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

2.  Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.

Authors:  Matthias Bauwens; Marijke De Saint-Hubert; Ellen Devos; Niko Deckers; Chris Reutelingsperger; Luc Mortelmans; Uwe Himmelreich; Felix M Mottaghy; Alfons Verbruggen
Journal:  Nucl Med Biol       Date:  2010-12-03       Impact factor: 2.408

Review 3.  Necrotic cell death in atherosclerosis.

Authors:  Wim Martinet; Dorien M Schrijvers; Guido R Y De Meyer
Journal:  Basic Res Cardiol       Date:  2011-05-25       Impact factor: 17.165

4.  Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress.

Authors:  D N Ku; D P Giddens; C K Zarins; S Glagov
Journal:  Arteriosclerosis       Date:  1985 May-Jun

5.  Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.

Authors:  Geralda A F van Tilborg; Esad Vucic; Gustav J Strijkers; David P Cormode; Venkatesh Mani; Torjus Skajaa; Chris P M Reutelingsperger; Zahi A Fayad; Willem J M Mulder; Klaas Nicolay
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

6.  Structural requirements for in vivo detection of cell death with 99mTc-annexin V.

Authors:  Jonathan F Tait; Christina Smith; Francis G Blankenberg
Journal:  J Nucl Med       Date:  2005-05       Impact factor: 10.057

7.  Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging.

Authors:  Heidi Kenis; Harmen Reinier Zandbergen; Leonard Hofstra; Artiom D Petrov; Ewald A Dumont; Francis D Blankenberg; Nezam Haider; Nicole Bitsch; Marion Gijbels; Johan W H Verjans; Navneet Narula; Jagat Narula; Chris P M Reutelingsperger
Journal:  J Nucl Med       Date:  2010-02       Impact factor: 10.057

8.  In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis.

Authors:  M Bauwens; M De Saint-Hubert; J Cleynhens; C Vandeputte; J Li; E Devos
Journal:  Q J Nucl Med Mol Imaging       Date:  2013-02-06       Impact factor: 2.346

9.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

Review 10.  Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.

Authors:  Alkystis Phinikaridou; Marcelo E Andia; Ajay M Shah; René M Botnar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-12       Impact factor: 4.733

View more
  9 in total

Review 1.  Nanotechnology in diagnosis and treatment of coronary artery disease.

Authors:  Mahdi Karimi; Hossein Zare; Amirala Bakhshian Nik; Narges Yazdani; Mohammad Hamrang; Elmira Mohamed; Parham Sahandi Zangabad; Seyed Masoud Moosavi Basri; Leila Bakhtiari; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2016-02-23       Impact factor: 5.307

2.  Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin.

Authors:  Zhonglin Liu; Brandon T Larsen; Lilach O Lerman; Brian D Gray; Christy Barber; Ahmad F Hedayat; Ming Zhao; Lars R Furenlid; Koon Y Pak; James M Woolfenden
Journal:  Nucl Med Biol       Date:  2016-05-19       Impact factor: 2.408

3.  A Comparison of [99mTc]Duramycin and [99mTc]Annexin V in SPECT/CT Imaging Atherosclerotic Plaques.

Authors:  Yan Hu; Guobing Liu; He Zhang; Yanli Li; Brian D Gray; Koon Y Pak; Hak Soo Choi; Dengfeng Cheng; Hongcheng Shi
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

Review 4.  Recent Advances in the Development of PET/SPECT Probes for Atherosclerosis Imaging.

Authors:  Yoichi Shimizu; Yuji Kuge
Journal:  Nucl Med Mol Imaging       Date:  2016-04-26

5.  Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type Diet.

Authors:  Dennis H M Kusters; Martijn L Chatrou; Brecht A G Willems; Marijke De Saint-Hubert; Matthias Bauwens; Emiel van der Vorst; Stefania Bena; Erik A L Biessen; Mauro Perretti; Leon J Schurgers; Chris P M Reutelingsperger
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

6.  Effects of Shenlian extract on experimental atherosclerosis in ApoE-deficient mice based on ultrasound biomicroscopy.

Authors:  Yan Guo; Xu-Cen Liu; Ya-Jie Wang; Qi Li; Qing Yang; Xiao-Gang Weng; Ying Chen; Wei-Yan Cai; Xiao-Xi Kan; Xi Chen; He-Fei Huang; Xiao-Xin Zhu; Yu-Jie Li
Journal:  BMC Complement Altern Med       Date:  2016-11-15       Impact factor: 3.659

Review 7.  Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases.

Authors:  Tao Li; Weitao Liang; Xijun Xiao; Yongjun Qian
Journal:  Int J Nanomedicine       Date:  2018-11-09

8.  Berberine inhibited carotid atherosclerosis through PI3K/AKTmTOR signaling pathway.

Authors:  Ting Song; Wei Da Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 9.  Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.

Authors:  Sara Gargiulo; Matteo Gramanzini; Marcello Mancini
Journal:  Int J Mol Sci       Date:  2016-09-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.